Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 2

Rates and Risk Factors for Interval Gastric Cancers at Screening Gastroscopy

Pages
194–202
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They might be reduced by increasing observation time, focusing on smaller lesions, and observing the low-to-mid-body of the stomach more carefully.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Backgrounds/Aims: Interval gastric cancers (GCs) can be encountered during screening gastroscopy.
📊
Key Findings & Data:This study investigated the rate of interval GCs and their risk factors.
💡
Conclusion & Impact:They might be reduced by increasing observation time, focusing on smaller lesions, and observing the low-to-mid-body of the stomach more carefully.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Özet

Backgrounds/Aims: Interval gastric cancers (GCs) can be encountered during screening gastroscopy. This study investigated the rate of interval GCs and their risk factors. Materials and Methods: We retrospectively investigated subjects who underwent screening gastroscopy from 2005 to 2017 in a university hospital and were diagnosed with GC. Subjects were grouped based on their endoscopic images and descriptive results into interval GC and initially diagnosed GC groups. Interval GCs were defined when endoscopic results within the previous 3 years were negative for GC. The clinico-pathological characteristics of the groups and risk factors for interval GCs were evaluated. Results: Of 54 724 subjects who underwent screening gastroscopy, 234 were diagnosed with GC, of which 43 were interval GCs. The rate of interval GCs was 18.4% (43/234, mean age 61.6 years). Interval GCs were smaller than initially diagnosed GCs (1.6 vs 1.9 cm, P = .011). They were located in the low-to-mid-body in 44.2%, antrum in 48.8%, and high body and cardia in 7%. Their observation time was shorter (248.74 vs 410.64 sec, P = .032). In multivariate analysis, they were associated with short observation time (odds ratio [OR] 0.99, 95% CI 0.994-0.998, P < .001) and location in the low-to-mid-body (OR 2.12, 95% CI 1.071-4.181, P = .031), although differentiation, ulcerated type, metaplasia, Helicobacter pylori infection, and endoscopists’ experience were not associated with interval GCs. Conclusions: The rate of interval GCs was significant during screening gastroscopy. They might be reduced by increasing observation time, focusing on smaller lesions, and observing the low-to-mid-body of the stomach more carefully.

🔖

Cite This Article

PARK, J. H., LEE, K. N., LEE, H. L., JUN, D. W., YOON, J. H., LEE, O. Y., YOON, B. C., CHOI, H. S. (2021). Rates and Risk Factors for Interval Gastric Cancers at Screening Gastroscopy. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 2, 194–202. https://ajindex.com/articles/408873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018
  2. 68(6):394- 424. [CrossRef] 2. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008
  3. 9(3):279- 287. [CrossRef] 3. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006
  4. 12(3):354-362. [CrossRef] 4. Lee JH, Kim JG, Jung HK, et al. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014
  5. 14(2):87-104. [CrossRef] 5. Japanese Gastric Cancer Association Registration C, Maruyama K, Kaminishi M, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006
  6. Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008
  7. 38(5):327-333. [CrossRef] 7. Gong EJ, Ahn JY, Jung HY, et al. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol. 2014
  8. 29(2):301-309. [CrossRef] 8. Choi KS, Jun JK, Park EC, et al. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS ONE. 2012
  9. 7(11):e50041. [CrossRef] 9. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006
  10. 12(30):4873-4874. [CrossRef] 10. Choi KS, Jun JK, Lee HY, et al. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci. 2011
  11. 102(8):1559-1564. [CrossRef] 11. Voutilainen ME, Juhola MT. Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur J Gastroenterol Hepatol. 2005
  12. 17(12):1345-1349. [CrossRef] 12. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010
  13. 362(19):1795-1803. [CrossRef] 13. Pimenta-Melo AR, Monteiro-Soares M, Libânio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016
  14. 28(9):1041-1049. [CrossRef] 14. Gong EJ, Lee JH, Jung K, et al. Characteristics of missed simultaneous gastric lesions based on double-check analysi